Qube Research & Technologies Ltd - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q1 2023$591,687
+60.5%
212,837
+99.1%
0.00%
+50.0%
Q4 2022$368,726
+372.7%
106,877
+254.0%
0.00%
Q3 2022$78,000
-92.2%
30,191
-87.6%
0.00%
-100.0%
Q1 2022$1,004,000
+52.1%
243,786
+248.3%
0.01%
-10.0%
Q1 2021$660,00069,9950.01%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders